{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:10Z","timestamp":1792831030472,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioorg.2026.110570","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:54:55Z","timestamp":1790175295000},"page":"110570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of pyrimidine-based dual CDK2\/TrkA inhibitors: Synthesis, antiproliferative activity, and mechanistic insights"],"prefix":"10.1016","volume":"183","author":[{"given":"Aya M.","family":"Slly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa A.","family":"Ewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed A.","family":"Bayoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid B.","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110570_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110570_bb0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41568-025-00824-9","article-title":"Acquired resistance in cancer: towards targeted therapeutic strategies","volume":"25","author":"Soragni","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110570_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111079","article-title":"Breakthrough in targeted therapy for non-small cell lung cancer","volume":"133","author":"Ye","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"24","key":"10.1016\/j.bioorg.2026.110570_bb0020","doi-asserted-by":"crossref","first-page":"17600","DOI":"10.3390\/ijms242417600","article-title":"An update on protein kinases as therapeutic targets\u2014part I: protein kinase C activation and its role in Cancer and cardiovascular diseases","volume":"24","author":"Silnitsky","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110570_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcancer.2022.12.006","article-title":"Semin., CDK inhibitors from past to present: a new wave of cancer therapy","volume":"88","author":"M.J. Mughal","year":"2023","journal-title":"Cancer Biol. Ther."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110570_bb0030","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1016\/j.bmc.2018.05.024","article-title":"Design, synthesis and biological evaluation of pyrimidine derivatives as novel CDK2 inhibitors that induce apoptosis and cell cycle arrest in breast cancer cells","volume":"26","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0035","doi-asserted-by":"crossref","unstructured":"F.A. Ikwu, Y. Isyaku, B.S. Obadawo, H.A. Lawal, S.A. Ajibowu, In silico design and molecular docking study of CDK2 inhibitors with potent cytotoxic activity against HCT116 colorectal cancer cell line, J. Genet. Eng. Biotechnol. 18(1) (2020) 51. https:\/\/doi.https:\/\/doi.org\/10.1186\/s43141-020-00066-2.","DOI":"10.1186\/s43141-020-00066-2"},{"key":"10.1016\/j.bioorg.2026.110570_bb0040","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/ijms22062806","article-title":"Inhibitors of cyclin-dependent kinases: types and their mechanism of action","volume":"22","author":"\u0141ukasik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110570_bb0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bioorg.2018.02.030","article-title":"Synthesis, anticancer evaluation, and molecular docking studies of some novel 4,6-disubstituted pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 (CDK2) inhibitors","volume":"79","author":"Cherukupalli","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110570_bb0050","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bmcl.2017.01.056","article-title":"The juxtamembrane region of TrkA kinase is critical for inhibitor selectivity","volume":"27","author":"Furuya","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110570_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115618","article-title":"Recent advances in the discovery of tropomyosin receptor kinases TRKs inhibitors: a mini review","volume":"258","author":"El-Nassan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0060","doi-asserted-by":"crossref","unstructured":"T.W. Laetsch, D.S. Hong, Tropomyosin receptor kinase inhibitors for the treatment of TRK fusion cancer, Clin. Cancer Res. 27(18) (2021) 4974\u20134982. https:\/\/doi.https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-0465.","DOI":"10.1158\/1078-0432.CCR-21-0465"},{"key":"10.1016\/j.bioorg.2026.110570_bb0065","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/onc.2009.61","article-title":"TrkA overexpression enhances growth and metastasis of breast cancer cells","volume":"28","author":"Lagadec","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110570_bb0070","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.molonc.2014.06.001","article-title":"The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition","volume":"8","author":"Ardini","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110570_bb0075","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/nm.3352","article-title":"Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer","volume":"19","author":"Vaishnavi","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.110570_bb0080","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1128\/MCB.20.23.8655-8666.2000","article-title":"Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia","volume":"20","author":"Reuther","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bioorg.2026.110570_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2009.10.009","article-title":"Rearrangements of NTRK1 gene in papillary thyroid carcinoma","volume":"321","author":"Greco","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bioorg.2026.110570_bb0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41419-019-1385-8","article-title":"Neurotrophins and their involvement in digestive cancers","volume":"10","author":"Blondy","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110570_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112025","article-title":"Dual-target kinase drug design: current strategies and future directions in cancer therapy","volume":"188","author":"Sun","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0100","doi-asserted-by":"crossref","unstructured":"N.M. Raghavendra, D. Pingili, S. Kadasi, A. Mettu, S. Prasad, Dual or multi-targeting inhibitors: the next generation anticancer agents, Eur. J. Med. Chem. 143 (2018) 1277\u20131300. https:\/\/doi:https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.021.","DOI":"10.1016\/j.ejmech.2017.10.021"},{"key":"10.1016\/j.bioorg.2026.110570_bb0105","doi-asserted-by":"crossref","unstructured":"Attia MH, Lasheen DS, Samir N, Taher AT, Abdel-Aziz HA, Abou El Ella DA. Design, synthesis and molecular modeling of pyrazolo[1,5-a]pyrimidine derivatives as dual inhibitors of CDK2 and TRKA kinases with antiproliferative activity. Pharmaceuticals (Basel) 2024 Dec 10;17(12):1667. https:\/\/doi:https:\/\/doi.org\/10.3390\/ph17121667.","DOI":"10.3390\/ph17121667"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110570_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00304948.2023.2225385","article-title":"Functionalized pyrimidines: synthetic approaches and biological activities. A review","volume":"56","author":"Bhatnagar","year":"2024","journal-title":"Org. Prep. Proced. Int."},{"key":"10.1016\/j.bioorg.2026.110570_bb0115","doi-asserted-by":"crossref","unstructured":"M.M. Alidmat, M. Khairuddean, N.M. Norman, A.N.M. Asri, M.H.M. Suhaimi, G. Sharma, Synthesis, characterization, docking study and biological evaluation of new chalcone, pyrazoline, and pyrimidine derivatives as potent antimalarial compounds, Arab. J. Chem. 14(9) (2021) 103304. https:\/\/doi:https:\/\/doi.org\/10.1016\/j.arabjc.2021.103304.","DOI":"10.1016\/j.arabjc.2021.103304"},{"key":"10.1016\/j.bioorg.2026.110570_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137802","article-title":"Biginelli dihydropyrimidines carrying azole rings: synthesis, computational studies, and evaluation of alpha-glucosidase inhibitory and antimicrobial activities","volume":"1306","author":"Ko\u00e7ak Aslan","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110570_bb0125","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1021\/acs.jmedchem.2c01647","article-title":"Structure\u2013activity relationship of novel pyrimidine derivatives with potent inhibitory activities against Mycobacterium tuberculosis","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0130","first-page":"1","article-title":"Novel pyrimidine derivatives containing an amide moiety: design, synthesis, and antifungal activity","volume":"73","author":"Wu","year":"2018","journal-title":"Chem. Pap."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110570_bb0135","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2174\/1389557523666221220142911","article-title":"Antiviral activity of pyrimidine containing compounds: patent review","volume":"23","author":"Farghaly","year":"2023","journal-title":"Mini-Rev. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110570_bb0140","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.3390\/ijms252011011","article-title":"Pyrimidine derivatives as selective COX-2 inhibitors with anti-inflammatory and antioxidant properties","volume":"25","author":"Tyli\u0144ska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110570_bb0145","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00044-011-9675-4","article-title":"Analgesic study of novel pyrimidine derivatives linked with coumarin moiety","volume":"21","author":"Gupta","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110570_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020784","article-title":"Synthesis of dihydropyrimidines: isosteres of nifedipine and evaluation of their calcium channel blocking efficiency","volume":"28","author":"Zohny","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110570_bb0155","first-page":"241","article-title":"Synthesis and in vitro antidiabetic screening of novel dihydropyrimidine derivatives","volume":"57","author":"Lalpara","year":"2021","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsps.2009.08.001","article-title":"Synthesis and anti-histaminic activity of some novel pyrimidines","volume":"17","author":"Shaik","year":"2009","journal-title":"Saudi Pharm. J."},{"issue":"15","key":"10.1016\/j.bioorg.2026.110570_bb0165","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1021\/acs.jmedchem.4c00861","article-title":"Discovery of novel pyrimidine-based derivatives as Nav1.2 inhibitors with efficacy in mouse models of epilepsy","volume":"67","author":"He","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1387923","article-title":"Design and synthesis of new dihydropyrimidine\/sulphonamide hybrids as promising anti-inflammatory agents via dual mPGES-1\/5-LOX inhibition","volume":"12","author":"Al-Wahaibi","year":"2024","journal-title":"Front. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2026.110570_bb0175","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1039\/D4RA01874E","article-title":"In the pursuit of novel therapeutic agents: synthesis, anticancer evaluation, and physicochemical insights of novel pyrimidine-based 2-aminobenzothiazole derivatives","volume":"14","author":"Ismail","year":"2024","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110570_bb0180","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.3390\/molecules28093664","article-title":"New Indazol-pyrimidine-based derivatives as selective anticancer agents: design, synthesis, and in silico studies","volume":"28","author":"Al-Tuwaijri","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110570_bb0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s43094-021-00274-8","article-title":"Pyrimidine: a review on anticancer activity with key emphasis on SAR","volume":"7","author":"Mahapatra","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110570_bb0190","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1039\/C8QO01233D","article-title":"Neglected sulfur(vi) pharmacophores in drug discovery: exploration of novel chemical space by the interplay of drug design and method development11Dedicated to professor Julius Rebek on the occasion of his 75th birthday","volume":"6","author":"L\u00fccking","year":"2019","journal-title":"Org. Chem. Front."},{"issue":"22","key":"10.1016\/j.bioorg.2026.110570_bb0195","doi-asserted-by":"crossref","first-page":"11871","DOI":"10.1039\/C8RA01440J","article-title":"SAR study on N2, N4-disubstituted pyrimidine-2,4-diamines as effective CDK2\/CDK9 inhibitors and antiproliferative agents","volume":"8","author":"Jing","year":"2018","journal-title":"RSC Adv."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110570_bb0200","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1158\/2159-8290.CD-15-0443","article-title":"An oncogenic NTRK fusion in a patient with soft-tissue sarcoma with response to the tropomyosin-related kinase inhibitor LOXO-101","volume":"5","author":"Doebele","year":"2015","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110570_bb0205","doi-asserted-by":"crossref","first-page":"E297","DOI":"10.1073\/pnas.1611577114","article-title":"Structural characterization of nonactive site, TrkA-selective kinase inhibitors","volume":"114","author":"Su","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2026.110570_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107413","article-title":"Molecular docking approach for the design and synthesis of new pyrazolopyrimidine analogs of roscovitine as potential CDK2 inhibitors endowed with pronounced anticancer activity","volume":"147","author":"Hamed","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114096","article-title":"Rational drug design to explore the structure-activity relationship (SAR) of TRK inhibitors with 2,4-diaminopyrimidine scaffold","volume":"230","author":"Wu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110570_bb0225","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1158\/1535-7163.MCT-09-0036","article-title":"Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway","volume":"8","author":"Thress","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"28","key":"10.1016\/j.bioorg.2026.110570_bb0230","doi-asserted-by":"crossref","first-page":"17427","DOI":"10.1039\/C6RA28102H","article-title":"Laccase-catalyzed green synthesis and cytotoxic activity of novel pyrimidobenzothiazoles and catechol thioethers","volume":"7","author":"Abdel-Mohsen","year":"2017","journal-title":"RSC Adv."},{"issue":"W1","key":"10.1016\/j.bioorg.2026.110570_bb0235","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110570_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107300","article-title":"2,3-Dichloronaphthoquinone derivatives: synthesis, antimicrobial activity, molecular modelling and ADMET studies","volume":"146","author":"Kolanc\u0131lar","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0245","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2026.110570_bb0250","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.imu.2017.11.002","article-title":"In silico drug design for Staphylococcus aureus and development of host-pathogen interaction network","volume":"10","author":"Wadapurkar","year":"2018","journal-title":"Inform. Med. Unlocked"},{"key":"10.1016\/j.bioorg.2026.110570_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110570_bb0260","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1432-1033.1997.0518a.x","article-title":"Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine","volume":"243","author":"De Azevedo","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128268","article-title":"Design, synthesis and antitumor activity evaluation of trifluoromethyl-substituted pyrimidine derivatives","volume":"51","author":"Liu","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110570_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114268","article-title":"Identification of novel chemotypes as CXCR2 antagonists via a scaffold hopping approach from a thiazolo[4,5-d]pyrimidine","volume":"235","author":"Van Hoof","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0275","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1080\/14756366.2022.2104841","article-title":"Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer","volume":"37","author":"Abdelsalam","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110570_bb0280","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/s41598-018-36089-6","article-title":"Bioactive glycoalkaloides isolated from Solanum melongena fruit peels with potential anticancer properties against hepatocellular carcinoma cells","volume":"9","author":"Fekry","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110570_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138951","article-title":"Synthesis, in-vitro, in-vivo screening, and molecular docking of disubstituted aminothiazole derivatives and their selenium nanoparticles as potential antiparkinson agents","volume":"1315","author":"El-Halaby","year":"2024","journal-title":"J. Mol. Struct."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:56:04Z","timestamp":1792828564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826011065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S0045206826011065"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110570","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of pyrimidine-based dual CDK2\/TrkA inhibitors: Synthesis, antiproliferative activity, and mechanistic insights","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110570"}}